Abstract

Single-cell transcriptomics and spatially-resolved imaging/sequencing technologies have revolutionized biomedical research. However, they suffer from lack of spatial information and a trade-off of resolution and gene coverage, respectively. We propose DOT, a multi-objective optimization framework for transferring cellular features across these data modalities, thus integrating their complementary information. DOT uses genes beyond those common to the data modalities, exploits the local spatial context, transfers spatial features beyond cell-type information, and infers absolute/relative abundance of cell populations at tissue locations. Thus, DOT bridges single-cell transcriptomics data with both high- and low-resolution spatially-resolved data. Moreover, DOT combines practical aspects related to cell composition, heterogeneity, technical effects, and integration of prior knowledge. Our fast implementation based on the Frank-Wolfe algorithm achieves state-of-the-art or improved performance in localizing cell features in high- and low-resolution spatial data and estimating the expression of unmeasured genes in low-coverage spatial data.

Single-cell and spatial omics come with a trade-off between resolution and gene coverage. Here, authors bridge this gap via DOT, a multi-objective optimisation model for localising cell features in high/low-resolution spatial data considering cell composition, heterogeneity, and technical effects.

Details

Title
DOT: a flexible multi-objective optimization framework for transferring features across single-cell and spatial omics
Author
Rahimi, Arezou 1 ; Vale-Silva, Luis A. 2   VIAFID ORCID Logo  ; Fälth Savitski, Maria 2 ; Tanevski, Jovan 3   VIAFID ORCID Logo  ; Saez-Rodriguez, Julio 4   VIAFID ORCID Logo 

 Heidelberg University & Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373); GlaxoSmithKline, Cellzome GmbH, Heidelberg, Germany (GRID:grid.420105.2) (ISNI:0000 0004 0609 8483) 
 GlaxoSmithKline, Cellzome GmbH, Heidelberg, Germany (GRID:grid.420105.2) (ISNI:0000 0004 0609 8483) 
 Heidelberg University & Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373); Jožef Stefan Institute, Department of Knowledge Technologies, Ljubljana, Slovenia (GRID:grid.445211.7) 
 Heidelberg University & Heidelberg University Hospital, Institute for Computational Biomedicine, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373) 
Pages
4994
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3066598915
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.